Moxyseyaro 0.5% Eye Drop - 10 ML

Antibiotic belongs to Fluoroquinolone group used in the treatment of bacterial conjunctivitis.

-For topical ophthalmic use only; not for injection. -Avoid touching tip of applicator to eye or other surfaces.

Skin rash, infection, conjunctivitis, decreased visual acuity, dry eye syndrome, eye discomfort, eye irritation, eye pain, eye pruritus, keratitis, lacrimation, ocular hyperemia, subconjunctival hemorrhage, otitis media, increased cough, pharyngitis, rhinitis and fever.

-Should not be given to patients suffering from hypersensitivity to moxifloxacin. -Intraocular administration may cause toxic anterior segment syndrome, which may consist of corneal edema and vitreous opacities. -Contact lenses should not be worn during therapy. -In case of over dose be ready to tell or show what was taken, how much and when it happened, and seek immediate medical attention. For additional information call us on 16676. Always tell your physician your detailed medical history.

-When administered orally or IV, moxifloxacin crosses the placenta. The amount of moxifloxacin available systemically following topical application of the ophthalmic drops is limited and significantly less in comparison to oral or IV doses. If ophthalmic agents are needed during pregnancy, the minimum effective dose should be used in combination with punctal occlusion for 3 to 5 minutes after application to decrease potential exposure to the fetus. -It is not known if moxifloxacin is present in breast milk following ophthalmic administration, the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits of treatment to the mother. -Ask your physician before taking any medication during pregnancy and lactation.

RAMEDA